DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE® (afamelanotide) and the future of photomedicine. Over 70 guests discussed the Company’s unique history and future growth potential at an invitation-only event in Düsseldorf.

DÜSSELDORF，德国，2024年3月28日（环球通讯社）--开创性的生物制药公司CLINUVEL昨天举办了一次广泛的市场简报会，讨论了其新药SCENESSE®（阿非拉诺肽）和光医学的未来。在杜塞尔多夫（Düsseldorf）举行的一次仅限邀请函的活动上，70多名嘉宾讨论了该公司独特的历史和未来的增长潜力。

Managing Director and CEO, Dr Philippe Wolgen shared the Company’s success in establishing profitability over the past seven financial years, building a strong balance sheet, commercialising the innovative melanocortin drug SCENESSE®, and plans to bring melanocortin technology to wider audiences with unmet needs.

董事总经理兼首席执行官Philippe Wolgen博士分享了该公司在过去七个财政年度取得的成功，建立了强大的资产负债表，将创新的黑皮质素药物SCENESSE®商业化，并计划将黑皮质素技术带给更多未满足需求的受众。

CLINUVEL is now investing heavily in R&D with an ambitious clinical pipeline, including a phase III clinical trial for the pigment loss disorder vitiligo. A case study presented at the American Academy of Dermatology Meeting on 9 March highlighted the systemic repigmentation of the skin of a female patient from the combination of SCENESSE® and phototherapy (light treatment).

CLINUVEL目前正在大力投资研发，并拥有一个雄心勃勃的临床管道，包括针对色素损失障碍白癜风的III期临床试验。3月9日在美国皮肤病学会会议上提出的一项案例研究强调了SCENESSE®和光疗（光治疗）相结合对女性患者皮肤的全身性色素沉着。

An estimated 45m individuals live with vitiligo globally, with no effective treatments for widespread depigmentation. The Company’s aspirations stretch beyond the clinical, with Dr Wolgen expanding upon the goal of making CLINUVEL a household name with the introduction of its PhotoCosmetics lines, incorporating novel melanocortin peptides.

据估计，全球有4500万人患有白癜风，对广泛的色素脱失没有有效的治疗方法。该公司的抱负超出了临床范围，Wolgen博士的目标是通过引入新型黑皮质素肽的光敏剂系列，使CLINUVEL成为家喻户晓的名字。

The consumer skincare lines are translating the Company’s targeted science into innovative products for the wider population. The lines were introduced to key US investors and celebrities during an intimate event at the home of Lady Gaga and longtime shareholder Michael Polansky in Malibu last month, resulting in positive feedback, a new international audience and anticipation for launch.

消费者护肤品系列正在将公司的目标科学转化为面向更广泛人群的创新产品。上个月，在Lady Gaga和长期股东迈克尔·波兰斯基（MichaelPolansky）位于马里布（Malibu）的家中举行的一次亲密活动中，这些台词被介绍给了美国主要投资者和名人，获得了积极的反馈，吸引了新的国际观众，并期待着上市。

“The pot.

“锅。